This inventor holds 1 USPTO granted patent. Top assignee: Micro-Leads, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Kevin Meador: Innovator in Spinal Cord Stimulation Technology
Introduction
Kevin Meador is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical technology, particularly in spinal cord stimulation methods. His innovative approach aims to improve the quality of life for individuals suffering from neural tissue-related issues.
Latest Patents
Kevin Meador holds a patent for a groundbreaking method titled "Spinal cord stimulation method to treat lateral neural tissues." This method involves providing an electrode array with a substrate that supports multiple stimulation contacts. These contacts are specifically designed to stimulate portions of the spinal cord neural tissue. The method also includes the implantation of the therapy array in a medically uncompressed manner within the epidural space. This positioning allows for effective stimulation adjacent to critical neural structures, enhancing therapeutic outcomes.
Career Highlights
Throughout his career, Kevin has demonstrated a commitment to advancing medical technology. His work at Micro-Leads, Inc. has been pivotal in developing innovative solutions for spinal cord stimulation. His dedication to research and development has led to significant advancements in the treatment of neural tissue disorders.
Collaborations
Kevin collaborates with talented professionals in his field, including Bryan McLaughlin and Girish Chitnis. These partnerships foster a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Kevin Meador's contributions to spinal cord stimulation technology exemplify his dedication to improving patient care. His innovative methods and collaborative spirit continue to drive advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile